Suppr超能文献

氨基酸烷基甲基丙烯酸盐共聚物 E/HCl 对体内难溶性药物吸收的影响。

Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drug.

机构信息

Pharmaceutical Research and Technology Labs , Astellas Pharma, Inc., 180 Ozumi, Yaizu, Shizuoka , Japan.

出版信息

Drug Dev Ind Pharm. 2013 Nov;39(11):1698-705. doi: 10.3109/03639045.2012.730525. Epub 2012 Oct 15.

Abstract

This study aimed to investigate in vivo absorption of tacrolimus formulated as a solid dispersion using Eudragit E®/HCl (E-SD). E-SD is an aminoalkyl methacrylate copolymer that can be dissolved under neutral pH conditions. E-SD was used alone as a solid dispersion carrier and/or was mixed with tacrolimus primarily dispersed with hydroxypropylmethylcellulose (HPMC). Tacrolimus was formulated with E-SD at several different ratios. Formulations with tacrolimus/E-SD ratio of 1/3 showed higher in vivo absorption, compared to tacrolimus dispersed in the excipients (primarily HPMC) found in commercially available tacrolimus capsules, using a rat in situ closed loop method. Good correlation was observed between in vitro drug solubility and in vivo drug absorption. In vitro solubility tests and rat oral absorption studies of tacrolimus/HPMC solid dispersion formulations were also conducted after mixing the HPMC dispersion with several ratios of E-SD. E-SD/tacrolimus/HPMC formulations yielded high in vitro drug solubility but comparatively low in vivo absorption. Dog oral absorption studies were conducted using capsules containing a formulation of tacrolimus/E-SD at a ratio of 1/5. The E-SD formulation-containing capsule showed higher in vivo drug absorption than tacrolimus dispersed in the standard HPMC capsule. These studies report enhancement of the in vivo absorption of a poorly water-soluble drug following dispersion with E-SD when compared to formulation in HPMC.

摘要

本研究旨在考察作为固体分散体使用 Eudragit E®/HCl(E-SD)的他克莫司的体内吸收情况。E-SD 是一种在中性 pH 条件下可溶解的氨烷基甲基丙烯酸酯共聚物。E-SD 单独用作固体分散体载体,或与主要以羟丙基甲基纤维素(HPMC)分散的他克莫司混合使用。他克莫司与 E-SD 以不同比例进行了配方。使用大鼠在体闭路循环法,与在市售他克莫司胶囊中发现的赋形剂(主要是 HPMC)分散的他克莫司相比,与 E-SD 以 1/3 比例配方的制剂显示出更高的体内吸收。观察到体外药物溶解度与体内药物吸收之间存在良好的相关性。还对 HPMC 分散体与 E-SD 的几种比例混合后的他克莫司/HPMC 固体分散制剂进行了体外溶解度试验和大鼠口服吸收研究。E-SD/他克莫司/HPMC 制剂具有较高的体外药物溶解度,但体内吸收相对较低。使用含有他克莫司/E-SD 比例为 1/5 的制剂的胶囊进行了犬口服吸收研究。含 E-SD 制剂的胶囊显示出比在标准 HPMC 胶囊中分散的他克莫司更高的体内药物吸收。这些研究报告了与在 HPMC 中制剂相比,将疏水性差的药物分散在 E-SD 中可增强其体内吸收。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验